Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-22-005823

Options or other derivatives

  • CEO acquired 392,312 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-02-14 Grant or award : show line 1 in the form Stock Option (Right to Buy) +297,037 $20.00 2032-02-13 297,037 297,037 D
2022-02-14 Grant or award : show line 2 in the form Restricted Stock Units +95,275 95,275 95,275 D
Loading xslF345X03/form4.xml…